Microglial and astroglial activation by 3, 4‐methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility. (15th November 2012)
- Record Type:
- Journal Article
- Title:
- Microglial and astroglial activation by 3, 4‐methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility. (15th November 2012)
- Main Title:
- Microglial and astroglial activation by 3, 4‐methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility
- Authors:
- Frau, Lucia
Simola, Nicola
Plumitallo, Antonio
Morelli, Micaela - Abstract:
- <abstract abstract-type="main" id="jnc12060-abs-0001"> <title>Abstract</title> <p>Evidence is accumulating to suggest that 3, 4‐methylenedioxymethamphetamine (MDMA) has neurotoxic and neuroinflammatory properties. MDMA is composed of two enantiomers with different biological activities. In this study, we evaluated the <italic>in vivo</italic> effects of S(+)‐MDMA, R(−)‐MDMA, and S(+)‐MDMA in combination with R(−)‐MDMA on microglial and astroglial activation compared with racemic MDMA, by assessment of complement type 3 receptor (CD11b) and glial fibrillary acidic protein (GFAP) immunoreactivity in the mouse striatum, nucleus accumbens, motor cortex, and substantia nigra. Motor activity and body temperature were also measured, to elucidate the physiological modifications paired with the observed glial changes. Similar to racemic MDMA (4 × 20 mg/kg), S(+)‐MDMA (4 × 10 mg/kg) increased both CD11b and GFAP in the striatum, although to a lower degree, whereas R(−)‐MDMA (4 × 10 mg/kg) did not induce any significant glial activation. Combined administration of S(+) plus R(−)‐MDMA did not induce any further activation compared with S(+)‐MDMA. In all other areas, only racemic MDMA was able to slightly activate the microglia, but not the astroglia, whereas enantiomers had no effect, either alone or in combination. Racemic MDMA and S(+)‐MDMA similarly increased motor activity and raised body temperature, whereas R(−)‐MDMA affected neither body temperature nor motor activity.<abstract abstract-type="main" id="jnc12060-abs-0001"> <title>Abstract</title> <p>Evidence is accumulating to suggest that 3, 4‐methylenedioxymethamphetamine (MDMA) has neurotoxic and neuroinflammatory properties. MDMA is composed of two enantiomers with different biological activities. In this study, we evaluated the <italic>in vivo</italic> effects of S(+)‐MDMA, R(−)‐MDMA, and S(+)‐MDMA in combination with R(−)‐MDMA on microglial and astroglial activation compared with racemic MDMA, by assessment of complement type 3 receptor (CD11b) and glial fibrillary acidic protein (GFAP) immunoreactivity in the mouse striatum, nucleus accumbens, motor cortex, and substantia nigra. Motor activity and body temperature were also measured, to elucidate the physiological modifications paired with the observed glial changes. Similar to racemic MDMA (4 × 20 mg/kg), S(+)‐MDMA (4 × 10 mg/kg) increased both CD11b and GFAP in the striatum, although to a lower degree, whereas R(−)‐MDMA (4 × 10 mg/kg) did not induce any significant glial activation. Combined administration of S(+) plus R(−)‐MDMA did not induce any further activation compared with S(+)‐MDMA. In all other areas, only racemic MDMA was able to slightly activate the microglia, but not the astroglia, whereas enantiomers had no effect, either alone or in combination. Racemic MDMA and S(+)‐MDMA similarly increased motor activity and raised body temperature, whereas R(−)‐MDMA affected neither body temperature nor motor activity. Interestingly, the increase in body temperature was correlated with glial activation. The results show that no synergism, but only additivity of effects, is caused by the combined administration of S(+)‐ and R(−)‐MDMA, and underline the importance of investigating the biochemical and behavioral properties of the two MDMA enantiomers to understand their relative contribution to the neuroinflammatory and neurotoxic effects of MDMA.</p> </abstract> … (more)
- Is Part Of:
- Journal of neurochemistry. Volume 124:Number 1(2013:Jan.)
- Journal:
- Journal of neurochemistry
- Issue:
- Volume 124:Number 1(2013:Jan.)
- Issue Display:
- Volume 124, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 124
- Issue:
- 1
- Issue Sort Value:
- 2013-0124-0001-0000
- Page Start:
- 69
- Page End:
- 78
- Publication Date:
- 2012-11-15
- Subjects:
- Neurochemistry -- Periodicals
616.8042 - Journal URLs:
- http://www.blackwell-synergy.com/loi/jnc ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jnc.12060 ↗
- Languages:
- English
- ISSNs:
- 0022-3042
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5021.500000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3702.xml